Skip to main content
SEEGENE, INC. logo

SEEGENE, INC. — Investor Relations & Filings

Ticker · 096530 ISIN · KR7096530001 KO Manufacturing
Open in API
Filings indexed 336 across all filing types
Latest filing 2026-03-19 Audit Report / Informat…
Country KR South Korea
Listing KO 096530

About SEEGENE, INC.

https://www.seegene.com/

Seegene, Inc. is a company specializing in molecular diagnostics. It develops and manufactures in vitro diagnostic (IVD) products and automated systems based on its proprietary multiplex real-time PCR technologies. These technologies enable the simultaneous detection of multiple pathogens from a single sample, facilitating a syndromic testing approach for various conditions. The company's portfolio includes a broad range of diagnostic assays for infectious diseases, including respiratory illnesses, sexually transmitted infections (STIs), and human papillomavirus (HPV). Seegene also provides automated platforms, such as its All-in-One systems, to streamline laboratory workflows. The company engages in technology-sharing initiatives and strategic collaborations to advance the standardization and accessibility of molecular diagnostics globally.

Recent filings

Filing Released Lang Actions
사업보고서 (2025.12)
Audit Report / Information Classification · 95% confidence The document is a comprehensive 'Audit Report' (감사보고서) for Seegene Inc. (주식회사 씨젠) for the fiscal year ending December 31, 2025. It includes the independent auditor's report, consolidated financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes. While it contains financial statements, it is primarily an audit report issued by an external accounting firm (Samjong KPMG) rather than the company's own 10-K annual report filing. Therefore, it is classified as an Audit Report. FY 2025
2026-03-19 Korean
감사보고서제출
Audit Report / Information Classification · 97% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from Seegene. It provides the audit opinion (unqualified/appropriate), key financial data (assets, liabilities, equity, profit/loss), and details regarding the audit process. While it contains financial data, it is a specific regulatory disclosure regarding the completion and submission of the audit report to the exchange, rather than the full Annual Report (10-K) or a simple announcement of publication (RPA). In the context of Korean regulatory filings (DART/KIND), this is classified as an Audit Report/Information filing. FY 2025
2026-03-17 Korean
신탁계약해지결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on the Termination of a Trust Agreement' (신탁계약해지결과보고서) filed by Seegene Inc. with the Financial Supervisory Service (FSS) in South Korea. It details the conclusion of a share repurchase trust contract, providing specific data on the acquisition of treasury shares through the trust and the final status of treasury holdings. This type of filing, which reports on the execution and completion of a share buyback program, falls under the category of 'Transaction in Own Shares' (POS).
2026-03-17 Korean
주요사항보고서(자기주식취득신탁계약해지결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities (Financial Services Commission/Korea Exchange) regarding the termination of a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 해지 결정). This is a direct report of a company's transaction involving its own shares (share buyback/termination of trust). According to the provided definitions, 'Transaction in Own Shares' (POS) is the correct category for reports of a company buying back or selling its own shares.
2026-03-11 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares Classification · 100% confidence The document is a formal regulatory filing titled '주요사항보고서(자기주식 처분 결정)' which translates to 'Report on Major Matters (Decision on Disposal of Treasury Shares)'. It details the company's decision to dispose of treasury shares to grant Restricted Stock Units (RSU) to employees. According to the filing definitions, reports regarding a company buying back or selling its own shares (share repurchase/issuance/disposal) are classified under the code 'POS' (Transaction in Own Shares).
2026-03-11 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of an upcoming Annual General Meeting (AGM) for the company Seegene. It details the meeting date, location, agenda items (such as financial statement approval, director appointments, and governance changes), and provides specific details on board and committee nominations. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the meeting and request their votes, which aligns with the PSI (Proxy Solicitation & Information Statement) category.
2026-03-11 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.